MedTrace Logo

Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics

NCT00157638 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1400

Last updated 2006-09-11

No results posted yet for this study

Summary

Recent health policy documents have endorsed an integrated model of collaboration between pharmacists and physicians in primary care. The integration of pharmacists into primary care has been identified as a priority for primary health care reform in Canada. However, the best way to do this has not been demonstrated or evaluated. This demonstration project shows the various ways in which pharmacists can be trained and integrated into different family practice settings, the processes and costs associated with doing this, and the outcomes observed. The main hypothesis is that pharmacist integration into family practice will optimize medication use, clinical care and clinical outcomes. This information provides policy makers with necessary information about collaboration between pharmacists and family physicians for their overall goal of reforming the delivery of primary health care to the population.

Conditions

Interventions

BEHAVIORAL

integration of pharmacist into primary care

DRUG

optimizing therapeutic treatments

BEHAVIORAL

optimizing processes of care

Sponsors & Collaborators

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Lisa Dolovich, PharmD, MSc · McMaster University

  • Kevin Pottie, MD · University of Ottawa, Ottawa ON

  • Janusz Kaczorowski, PhD · McMaster University

  • Barbara Farrell, PharmD · Elisabeth Bruyere Research Institute, Ottawa, ON

Study Design

Allocation
RANDOMIZED
Purpose
ECT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Completion
2006-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00157638 on ClinicalTrials.gov